Global Sexually Transmitted Diseases (STDs) Drug Market Insights and Forecast to 2031

Report ID: 1564768 | Published Date: Oct 2024 | No. of Page: 112 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Sexually Transmitted Diseases (STDs) Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Chlamydia
        1.2.3 Gonorrhea
        1.2.4 Syphilis
        1.2.5 Genital herpes
        1.2.6 HPV
        1.2.7 HIV / AIDS
    1.3 Market by Application
        1.3.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Sexually Transmitted Diseases (STDs) Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Sexually Transmitted Diseases (STDs) Drug Sales by Region
        2.4.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Sexually Transmitted Diseases (STDs) Drug by Region (2023-2028)
    2.5 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region
        2.5.1 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2017-2022)
        2.5.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers
        3.1.1 Global Top Sexually Transmitted Diseases (STDs) Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sexually Transmitted Diseases (STDs) Drug in 2021
    3.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers
        3.2.1 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STDs) Drug Revenue in 2021
    3.3 Global Sexually Transmitted Diseases (STDs) Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Sexually Transmitted Diseases (STDs) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Sexually Transmitted Diseases (STDs) Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Type
        4.1.1 Global Sexually Transmitted Diseases (STDs) Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Sexually Transmitted Diseases (STDs) Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    4.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Type
        4.2.1 Global Sexually Transmitted Diseases (STDs) Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Sexually Transmitted Diseases (STDs) Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Sexually Transmitted Diseases (STDs) Drug Price by Type
        4.3.1 Global Sexually Transmitted Diseases (STDs) Drug Price by Type (2017-2022)
        4.3.2 Global Sexually Transmitted Diseases (STDs) Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Application
        5.1.1 Global Sexually Transmitted Diseases (STDs) Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Sexually Transmitted Diseases (STDs) Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    5.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Application
        5.2.1 Global Sexually Transmitted Diseases (STDs) Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Sexually Transmitted Diseases (STDs) Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Sexually Transmitted Diseases (STDs) Drug Price by Application
        5.3.1 Global Sexually Transmitted Diseases (STDs) Drug Price by Application (2017-2022)
        5.3.2 Global Sexually Transmitted Diseases (STDs) Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Sexually Transmitted Diseases (STDs) Drug Market Size by Type
        6.1.1 North America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2028)
        6.1.2 North America Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2028)
    6.2 North America Sexually Transmitted Diseases (STDs) Drug Market Size by Application
        6.2.1 North America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2028)
        6.2.2 North America Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2028)
    6.3 North America Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        6.3.1 North America Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2028)
        6.3.2 North America Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Sexually Transmitted Diseases (STDs) Drug Market Size by Type
        7.1.1 Europe Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2028)
        7.1.2 Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2028)
    7.2 Europe Sexually Transmitted Diseases (STDs) Drug Market Size by Application
        7.2.1 Europe Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2028)
        7.2.2 Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2028)
    7.3 Europe Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        7.3.1 Europe Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2028)
        7.3.2 Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Market Size by Type
        8.1.1 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Market Size by Application
        8.2.1 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Market Size by Region
        8.3.1 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Sexually Transmitted Diseases (STDs) Drug Market Size by Type
        9.1.1 Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2028)
        9.1.2 Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2028)
    9.2 Latin America Sexually Transmitted Diseases (STDs) Drug Market Size by Application
        9.2.1 Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2028)
        9.2.2 Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2028)
    9.3 Latin America Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        9.3.1 Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2028)
        9.3.2 Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Market Size by Type
        10.1.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Market Size by Application
        10.2.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        10.3.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 Hoffmann La Roche
        11.2.1 Hoffmann La Roche Corporation Information
        11.2.2 Hoffmann La Roche Overview
        11.2.3 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Hoffmann La Roche Recent Developments
    11.3 Bayer Healthcare
        11.3.1 Bayer Healthcare Corporation Information
        11.3.2 Bayer Healthcare Overview
        11.3.3 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer Healthcare Recent Developments
    11.4 Eli Lilly
        11.4.1 Eli Lilly Corporation Information
        11.4.2 Eli Lilly Overview
        11.4.3 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eli Lilly Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Corporation Information
        11.5.2 Johnson & Johnson Overview
        11.5.3 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Corporation Information
        11.6.2 Bristol-Myers Squibb Overview
        11.6.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 AbbVie, Inc.
        11.7.1 AbbVie, Inc. Corporation Information
        11.7.2 AbbVie, Inc. Overview
        11.7.3 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 AbbVie, Inc. Recent Developments
    11.8 Gilead Sciences
        11.8.1 Gilead Sciences Corporation Information
        11.8.2 Gilead Sciences Overview
        11.8.3 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Gilead Sciences Recent Developments
    11.9 GlaxoSmithKline Plc
        11.9.1 GlaxoSmithKline Plc Corporation Information
        11.9.2 GlaxoSmithKline Plc Overview
        11.9.3 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 GlaxoSmithKline Plc Recent Developments
    11.10 Merck & Co., Inc.
        11.10.1 Merck & Co., Inc. Corporation Information
        11.10.2 Merck & Co., Inc. Overview
        11.10.3 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Merck & Co., Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Sexually Transmitted Diseases (STDs) Drug Industry Chain Analysis
    12.2 Sexually Transmitted Diseases (STDs) Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Sexually Transmitted Diseases (STDs) Drug Production Mode & Process
    12.4 Sexually Transmitted Diseases (STDs) Drug Sales and Marketing
        12.4.1 Sexually Transmitted Diseases (STDs) Drug Sales Channels
        12.4.2 Sexually Transmitted Diseases (STDs) Drug Distributors
    12.5 Sexually Transmitted Diseases (STDs) Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Sexually Transmitted Diseases (STDs) Drug Industry Trends
    13.2 Sexually Transmitted Diseases (STDs) Drug Market Drivers
    13.3 Sexually Transmitted Diseases (STDs) Drug Market Challenges
    13.4 Sexually Transmitted Diseases (STDs) Drug Market Restraints
14 Key Findings in The Global Sexually Transmitted Diseases (STDs) Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Chlamydia
    Table 3. Major Manufacturers of Gonorrhea
    Table 4. Major Manufacturers of Syphilis
    Table 5. Major Manufacturers of Genital herpes
    Table 6. Major Manufacturers of HPV
    Table 7. Major Manufacturers of HIV / AIDS
    Table 8. Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Sexually Transmitted Diseases (STDs) Drug Sales by Region (2017-2022) & (K Units)
    Table 11. Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Region (2017-2022)
    Table 12. Global Sexually Transmitted Diseases (STDs) Drug Sales by Region (2023-2028) & (K Units)
    Table 13. Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Region (2023-2028)
    Table 14. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Region (2017-2022)
    Table 16. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Region (2023-2028)
    Table 18. Global Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Manufacturers (2017-2022)
    Table 20. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Manufacturers (2017-2022)
    Table 22. Sexually Transmitted Diseases (STDs) Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Sexually Transmitted Diseases (STDs) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Sexually Transmitted Diseases (STDs) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STDs) Drug as of 2021)
    Table 25. Sexually Transmitted Diseases (STDs) Drug Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Offered
    Table 27. Date of Manufacturers Enter into Sexually Transmitted Diseases (STDs) Drug Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2022) & (K Units)
    Table 30. Global Sexually Transmitted Diseases (STDs) Drug Sales by Type (2023-2028) & (K Units)
    Table 31. Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Type (2017-2022)
    Table 32. Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Type (2023-2028)
    Table 33. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Type (2017-2022)
    Table 36. Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Type (2023-2028)
    Table 37. Sexually Transmitted Diseases (STDs) Drug Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Sexually Transmitted Diseases (STDs) Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2022) & (K Units)
    Table 40. Global Sexually Transmitted Diseases (STDs) Drug Sales by Application (2023-2028) & (K Units)
    Table 41. Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Application (2017-2022)
    Table 42. Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Application (2023-2028)
    Table 43. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Application (2017-2022)
    Table 46. Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Application (2023-2028)
    Table 47. Sexually Transmitted Diseases (STDs) Drug Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Sexually Transmitted Diseases (STDs) Drug Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2022) & (K Units)
    Table 50. North America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2023-2028) & (K Units)
    Table 51. North America Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2022) & (K Units)
    Table 54. North America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2023-2028) & (K Units)
    Table 55. North America Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2022) & (K Units)
    Table 58. North America Sexually Transmitted Diseases (STDs) Drug Sales by Country (2023-2028) & (K Units)
    Table 59. North America Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Sexually Transmitted Diseases (STDs) Drug Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Sexually Transmitted Diseases (STDs) Drug Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Sexually Transmitted Diseases (STDs) Drug Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Sexually Transmitted Diseases (STDs) Drug Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Pfizer Corporation Information
    Table 110. Pfizer Description and Major Businesses
    Table 111. Pfizer Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Pfizer Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Pfizer Recent Developments
    Table 114. Hoffmann La Roche Corporation Information
    Table 115. Hoffmann La Roche Description and Major Businesses
    Table 116. Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Hoffmann La Roche Recent Developments
    Table 119. Bayer Healthcare Corporation Information
    Table 120. Bayer Healthcare Description and Major Businesses
    Table 121. Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Bayer Healthcare Recent Developments
    Table 124. Eli Lilly Corporation Information
    Table 125. Eli Lilly Description and Major Businesses
    Table 126. Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Eli Lilly Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Eli Lilly Recent Developments
    Table 129. Johnson & Johnson Corporation Information
    Table 130. Johnson & Johnson Description and Major Businesses
    Table 131. Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Johnson & Johnson Recent Developments
    Table 134. Bristol-Myers Squibb Corporation Information
    Table 135. Bristol-Myers Squibb Description and Major Businesses
    Table 136. Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Bristol-Myers Squibb Recent Developments
    Table 139. AbbVie, Inc. Corporation Information
    Table 140. AbbVie, Inc. Description and Major Businesses
    Table 141. AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. AbbVie, Inc. Recent Developments
    Table 144. Gilead Sciences Corporation Information
    Table 145. Gilead Sciences Description and Major Businesses
    Table 146. Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Gilead Sciences Recent Developments
    Table 149. GlaxoSmithKline Plc Corporation Information
    Table 150. GlaxoSmithKline Plc Description and Major Businesses
    Table 151. GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. GlaxoSmithKline Plc Recent Developments
    Table 154. Merck & Co., Inc. Corporation Information
    Table 155. Merck & Co., Inc. Description and Major Businesses
    Table 156. Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Merck & Co., Inc. Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Sexually Transmitted Diseases (STDs) Drug Distributors List
    Table 162. Sexually Transmitted Diseases (STDs) Drug Customers List
    Table 163. Sexually Transmitted Diseases (STDs) Drug Market Trends
    Table 164. Sexually Transmitted Diseases (STDs) Drug Market Drivers
    Table 165. Sexually Transmitted Diseases (STDs) Drug Market Challenges
    Table 166. Sexually Transmitted Diseases (STDs) Drug Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sexually Transmitted Diseases (STDs) Drug Product Picture
    Figure 3. Global Sexually Transmitted Diseases (STDs) Drug Market Share by Type in 2021 & 2028
    Figure 3. Chlamydia Product Picture
    Figure 4. Gonorrhea Product Picture
    Figure 5. Syphilis Product Picture
    Figure 6. Genital herpes Product Picture
    Figure 7. HPV Product Picture
    Figure 8. HIV / AIDS Product Picture
    Figure 9. Global Sexually Transmitted Diseases (STDs) Drug Market Share by Application in 2021 & 2028
    Figure 10. Hospital Pharmacies
    Figure 11. Retail Pharmacies
    Figure 12. Online Pharmacies
    Figure 13. Sexually Transmitted Diseases (STDs) Drug Report Years Considered
    Figure 14. Global Sexually Transmitted Diseases (STDs) Drug Sales 2017-2028 (K Units)
    Figure 15. Global Sexually Transmitted Diseases (STDs) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Sexually Transmitted Diseases (STDs) Drug Revenue 2017-2028 (US$ Million)
    Figure 17. Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Region (2017-2022)
    Figure 19. Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Region (2023-2028)
    Figure 20. North America Sexually Transmitted Diseases (STDs) Drug Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Sexually Transmitted Diseases (STDs) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Sexually Transmitted Diseases (STDs) Drug Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Sexually Transmitted Diseases (STDs) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Sexually Transmitted Diseases (STDs) Drug Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Sexually Transmitted Diseases (STDs) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Sexually Transmitted Diseases (STDs) Drug in the World: Market Share by Sexually Transmitted Diseases (STDs) Drug Revenue in 2021
    Figure 32. Global Sexually Transmitted Diseases (STDs) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    Figure 34. Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    Figure 35. Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    Figure 36. Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    Figure 37. North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    Figure 38. North America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    Figure 39. North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    Figure 40. North America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    Figure 41. North America Sexually Transmitted Diseases (STDs) Drug Sales Share by Country (2017-2028)
    Figure 42. North America Sexually Transmitted Diseases (STDs) Drug Revenue Share by Country (2017-2028)
    Figure 43. U.S. Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    Figure 46. Europe Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    Figure 48. Europe Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Sexually Transmitted Diseases (STDs) Drug Sales Share by Country (2017-2028)
    Figure 50. Europe Sexually Transmitted Diseases (STDs) Drug Revenue Share by Country (2017-2028)
    Figure 51. Germany Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. France Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue Share by Region (2017-2028)
    Figure 62. China Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. India Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. China Taiwan Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Sexually Transmitted Diseases (STDs) Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America Sexually Transmitted Diseases (STDs) Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Sexually Transmitted Diseases (STDs) Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Sexually Transmitted Diseases (STDs) Drug Value Chain
    Figure 90. Sexually Transmitted Diseases (STDs) Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Hoffmann La Roche
Bayer Healthcare
Eli Lilly
Johnson & Johnson
Bristol-Myers Squibb
AbbVie, Inc.
Gilead Sciences
GlaxoSmithKline Plc
Merck & Co., Inc.
Frequently Asked Questions
Sexually Transmitted Diseases (STDs) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sexually Transmitted Diseases (STDs) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sexually Transmitted Diseases (STDs) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Urine Test Strips

Urine Test Strips market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Urine Reagent Strips

Urine Reagent Strips market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Hydroxyprogesterone

Hydroxyprogesterone market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More